American International Group’s Exagen XGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-5,125
Closed -$41K 3283
2022
Q1
$41K Sell
5,125
-361
-7% -$3.11K ﹤0.01% 2911
2021
Q4
$64K Sell
5,486
-163
-3% -$1.91K ﹤0.01% 2883
2021
Q3
$77K Sell
5,649
-422
-7% -$5.61K ﹤0.01% 2891
2021
Q2
$91 Buy
6,071
+3,288
+118% +$50.4K ﹤0.01% 2900
2021
Q1
$49 Buy
2,783
+7
+0.3% +$125 ﹤0.01% 2988
2020
Q4
$37 Sell
2,776
-79
-3% -$1.12K ﹤0.01% 3020
2020
Q3
$31K Sell
2,855
-65
-2% -$837 ﹤0.01% 3000
2020
Q2
$36K Buy
2,920
+959
+49% +$13K ﹤0.01% 2975
2020
Q1
$31K Sell
1,961
-113
-5% -$2.24K ﹤0.01% 2838
2019
Q4
$53K Buy
+2,074
New +$36.9K ﹤0.01% 2866

Other funds holding XGN

American International Group's XGN Position: Q2 2022 in Review

American International Group sold out of Exagen (XGN) in Q2 2022, closing a stake of 5,125 shares — an estimated $41K sold.

American International Group first reported a position in XGN in Q4 2019 and held it in 10 quarters. The position peaked at $77K in Q3 2021. 47 funds tracked by Wall St. Rank hold XGN as of Q2 2022.

  • American International Group reported no remaining Exagen position as of Q2 2022 after selling out during the quarter.
  • American International Group sold 5,125 Exagen shares in Q2 2022, an estimated $41K.
  • American International Group first reported a position in Exagen in Q4 2019 and held it in 10 quarters.
  • American International Group's Exagen position peaked at $77K in Q3 2021.
  • 47 funds tracked by Wall St. Rank held Exagen as of Q2 2022.

Based on American International Group's 13F filing for Q2 2022, filed 12 Aug 2022.